|Videos|March 30, 2022
Biomarker Testing: Methodologies, Sample Types, and Emerging Data
Author(s)Mehmet Asim Bilen, MD
Mehmet Asim Bilen, MD weighs in on various biomarker testing methodologies, sample considerations, and emerging data on novel biomarkers.
Advertisement
Episodes in this series
Advertisement
Related to this article
“What we are trying to do more often is to ablate as much as we can,” said Shankar Siva, MBBS, PhD, FRANZCR, on pairing SABR with systemic therapy in RCC.
Triplets did not beat pembrolizumab plus lenvatinib in frontline RCC, while belzutifan plus lenvatinib and perioperative pembrolizumab showed benefit.
Advertisement
Advertisement
Trending on CancerNetwork
1
Predicting Severe Immune-Related Toxicities in Lung Cancer Immunotherapy
2
Recapping GI Cancer at ESMO 2026: Standout Data From Phase 1 to Phase 3
3
EU Approves T-DXd for HER2+ Early Breast Cancer With Residual Disease
4
Outpatient Treatment-Related Toxicity After Hospital Discharge Among Patients Receiving Lifileucel for Advanced Melanoma
5